Table 2. Hypoglycemic activity of ZnONPs.

Groups	Blood glucose levels (mmol/l)
	Dose	Fasting glucose levels at 0 h	Glucose levels after 2 h	% of inhibition
G-I (Control: Distilled water)	1 ml/ mice (oral)	4.10 ± 0.12	3.98 ± 0.06	-
G-II (ZnONPs, mild dose)	8 mg/kg b.w. (oral)	3.84 ± 0.19	2.98 ± 0.15*	25.13
G-III (ZnONPs, moderate dose)	14 mg/kg b.w. (oral)	4.12 ± 0.13	2.82 ± 0.12†	29.15
G-IV (Standard: Glibenclamide)	10 mg/kg b.w. (oral)	4.04 ± 0.10	2.02 ± 0.15†	49.25

Mean ± S.E.M. (n=5). Data were analyzed using one-way ANOVA followed by Dunnett’s t test and compared with control.

^*P<0.01.

^†P<0.005 was considered significant.